₹90.05 2.65 (3.03%)
As on August 20, 2026
Sotac Pharmaceuticals Ltd. is an India-based company operating within the pharmaceutical industry, specializing in the manufacturing of a diverse range of pharmaceutical formulations. The company functions primarily as a Contract Development and Manufacturing Organization (CDMO) and third-party manufacturer, serving both domestic and international clients. Its product portfolio includes various finished formulations such as tablets (general, beta-lactam, coated, and uncoated), capsules (general and beta-lactam), oral liquids, dry syrups, and external preparations like nasal sprays, relief sprays, and creams. Sotac Pharmaceuticals produces pharmaceuticals across numerous therapeutic areas, including anti-diabetic, anti-psychotic, vitamin and mineral supplements, anti-cold, anti-allergic, dermatological, antacid, anti-ulcerant, anti-emetic, cardiac, anti-hypertensive, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (both IP-Lactams and Non-IP-Lactams), anti-fungal, and cephalosporin products. Beyond manufacturing, the company provides essential services to the pharmaceutical sector, including regulatory services, containment solutions, formulation development, clinical batch production, commercial scale production, and packaging. Sotac Pharmaceuticals exports to over 20 countries globally, with the United States being a significant international market, and maintains a strong presence across 14 major states in India.
Total Revenue (YTD)
₹1.0KCAGR 5-Year
+8.46%Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.